$OCGN for those new here WHO approval means many of the 60 or so countries with pending eua for Covaxin become approved. BB is having trouble with demand in India and is working on distributing via their vaccine maitre so the rest of those countries need to order elsewhere. Ocugen is BB’s only international manufacturing partner. Keep in mind africa is still only at 4% vaccination rate as are most other developing countries - where mrna vaccines can’t be distributed given the need for extreme cold storage, not available (who is pushing for vaccine equity and global rates to increase) . Covaxin doesnt require extreme cold storage so is easy to distribute and stockpile for years to come.
12
13
13 Likes